financetom
Business
financetom
/
Business
/
Lazard Closes $400 Million Notes Offering to Redeem Existing Debt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lazard Closes $400 Million Notes Offering to Redeem Existing Debt
Mar 12, 2024 2:39 PM

05:26 PM EDT, 03/12/2024 (MT Newswires) -- Lazard ( LAZ ) late Tuesday said it closed its $400 million offering of 6.00% senior notes due 2031.

The plans use proceeds from the offering to redeem its outstanding 3.75% senior notes maturing in 2025.

The tender offer for the 3.75% notes was scheduled to expire at 5 p.m. ET on Tuesday, with bondholders receiving $987.80 for each $1,000 of the notes they tender, plus any accrued and unpaid interest.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BYD factory delayed in Brazil to be 'fully functional' by end-2026, says official
BYD factory delayed in Brazil to be 'fully functional' by end-2026, says official
May 26, 2025
RIO DE JANEIRO (Reuters) -Chinese electric car maker BYD's new factory in Brazil will be fully functional by December 2026, after its operations were delayed because of an investigation into labor abuses, Bahia state labor secretary Augusto Vasconcelos said in a video on Monday. By the end of this year, the factory should start producing cars from semi-finished kits, he...
Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio
Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio
May 26, 2025
In April, Medicus Pharma Ltd. ( MDCX ) agreed to acquire all of Antev’s issued and outstanding shares on a share exchange. Antev is a clinical-stage biotech company developing Teverelix, a next-generation GnRH antagonist, as the first in-market product for cardiovascular high-risk prostate cancer patients and patients with first acute urinary retention (AURr) episodes due to an enlarged prostate. Medicus...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Why Is Apogee Therapeutics Stock Trading Higher On Monday?
Why Is Apogee Therapeutics Stock Trading Higher On Monday?
May 26, 2025
Apogee Therapeutics, Inc. ( APGE ) on Monday revealed interim data from its Phase 1b trial of APG808, a novel half-life extended IL-4Rα antibody, in patients with mild-to-moderate asthma. The Phase 1b double-blind, placebo-controlled, multiple-dose trial evaluated the safety and tolerability of APG808 in 22 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide concentration (FeNO),...
Copyright 2023-2026 - www.financetom.com All Rights Reserved